Schonfeld Strategic Advisors’s Taysha Gene Therapies TSHA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-843,200
| Closed | -$1.69M | – | 2243 |
|
|
2024
Q3 | $1.69M | Buy |
843,200
+74,000
| +10% | +$149K | 0.01% | 831 |
|
|
2024
Q2 | $1.72M | Buy |
769,200
+216,605
| +39% | +$485K | 0.01% | 860 |
|
|
2024
Q1 | $1.59M | Sell |
552,595
-566,780
| -51% | -$1.63M | 0.01% | 906 |
|
|
2023
Q4 | $1.98M | Buy |
1,119,375
+399,332
| +55% | +$707K | 0.01% | 740 |
|
|
2023
Q3 | $2.28M | Buy |
+720,043
| New | +$2.28M | 0.02% | 687 |
|
|
2022
Q4 | – | Sell |
-11,000
| Closed | -$22K | – | 2903 |
|
|
2022
Q3 | $22K | Sell |
11,000
-13,100
| -54% | -$26.2K | ﹤0.01% | 2640 |
|
|
2022
Q2 | $90K | Buy |
24,100
+4,100
| +21% | +$15.3K | ﹤0.01% | 2084 |
|
|
2022
Q1 | $131K | Buy |
+20,000
| New | +$131K | ﹤0.01% | 2091 |
|